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1070Abstract
Background Cancer has long inspired fear, but the effect of fear is not well understood; it
seems both to facilitate and to deter early diagnosis behaviours. To elucidate fear's behavioural
effects, we systematically reviewed and synthesised qualitative literature to explore what people
fear about cancer.
Methods We searched Medline, Embase, PsycInfo, Web of Science, AnthroSource, and
Anthrobase for studies on cancer fear in breast, cervical, and colorectal cancer screening and
analysed 102 studies from 26 countries using thematic synthesis.
Results Fears of cancer emanated from a core view of cancer as a vicious, unpredictable, and
indestructible enemy, evoking fears about its proximity, the (lack of) strategies to keep it at bay,
the personal and social implications of succumbing, and fear of dying from cancer.
Conclusions This view of cancer as ‘an enemy’ reprises the media's ‘war on cancer’ theme and
may affect the acceptance of cancer early detection and prevention messages, since cancer's
characteristics influenced whether ‘fight’ or ‘flight’ was considered appropriate.
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Cancer has long inspired fear. Despite advances in early diagnosis and
treatment of many cancers, a third to half the general population in
the United States and United Kingdom say they fear cancer more than
any other disease.1,2 Population‐based studies have consistently
shown that about a quarter to half the population worry to some extent
about getting cancer, with 5%–10% experiencing extreme worry.2–4
On a population level, even thesemodest percentages equate to a great
number of people experiencing significant cancer worry. Fear in itself is
unpleasant and burdensome, but it may also affect behaviour, although
its behavioural effects are not well understood. Some quantitative
studies suggest that it deters help‐seeking and screening for cancer,5,6
others that it has a motivating effect,7,8 and some find both.2,9e Creative Commons Attribution Li
by John Wiley & Sons Ltd.
wileyonlinelibrary.comThese contradictory findings have led some authors to suggest
that the effect may depend on the focus of the fear itself.6,9–11
For example, ‘cancer’ may be associated with perceptions of treat-
ment, incapacitation, and death, and these could be considered sep-
arate fears relating to cancer. The discrepant findings of quantitative
studies regarding fear's behavioural effects might then be explained
by differences in the operationalisation of cancer fear across studies.
For example, fear of ‘getting cancer’ may facilitate cancer screening
participation to obtain reassurance, while fear about cancer treat-
ments may be a barrier to screening to avoid being diagnosed.11
To date, there is no comprehensive overview of the various fears
that people may have regarding cancer. Until we understand what
it is about cancer that evokes fear, it is difficult to know how best
to measure cancer fear, how to allay undue or counterproductive
fears, or how to encourage adaptive behaviours in those who may
be deterred by their fears.cense, which permits use, distribution and reproduction in any medium, provided
Psycho‐Oncology. 2017;26:1070–1079./journal/pon
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provoked by cancer that are prevalent in the general, asymptomatic
population, through a systematic review and meta‐synthesis of the
qualitative literature. We focus on qualitative research because it does
not rely on any specific operationalisation of the concept ‘cancer fear’
and allows participants to express their cancer fears in their own
words. We use screening as the context because this is the setting in
which beliefs about cancer in the healthy, asymptomatic population
have usually been explored. To our knowledge, this is the first study
to triangulate and synthesise qualitative evidence to create a deeper
understanding of the various fears evoked by cancer in the general
population, which can be used as a starting point for linking cancer
fears to approach or avoidance behaviours.2 | METHODS
2.1 | Definition of cancer fear
‘Cancer fear’ was defined as any fear, anxiety, or worry related to
cancer, including causes or consequences of cancer that served as
proxies for cancer fear, such as fear of treatment for cancer. Although
some authors suggest that ‘cancer fear’ and ‘cancer worry’ are concep-
tually different,6,10 we took an inclusive approach because these
distinctions are poorly understood. References to test‐specific fears
(eg, pain or cost) were excluded from the analysis because we
considered them not specific to cancer.2.2 | Scope of search
To explore the cancer fears prevalent in the general population (as
opposed to fears that may be prompted by possible cancer symptoms
in a symptomatic population, or fears prompted by previous experi-
ences or symptoms in a cancer patient population), we limited our
review to studies conducted in the context of population screening
for breast, cervical, or colorectal cancer (CRC). These are the most
widely recommended cancer screenings.TABLE 1 Inclusion and exclusion criteria
Inclusion criteria
Qualitative or mixed methods
Breast, cervical, or CRC screening
Reference(s) to cancer fear in results section or
supplementary results files
Exclusion criteria
No cancer fears
No original research article
Sample not eligible for screening (or only partially and results for
eligible sample not described separately)
Purposive high risk sample, for example, genetic risk
Only clinical or self‐breast examination screening methods
aKosters JP, Gotzsche PC. Regular self‐examination or clinical examination fo
CD003373.2.3 | Search strategy and selection criteria
We systematically searched PubMed, EMBASE, PsycInfo,
AnthroSource, Anthrobase, and Web of Science from January 1992
until March 2015 (updated from an initial search carried out in June
2013), using the following search terms and Boolean connectors: (can-
cer OR neoplasm) AND (fear OR worry OR anxiety) AND (screening
OR breast OR mammography OR colorectal OR colonoscopy OR FOBt
OR occult blood OR sigmoidoscopy OR cervical OR Pap OR cytology).
The electronic searches were augmented by hand searching the refer-
ence lists of included studies. Inclusion criteria were qualitative or
mixed methods studies published in English and digitally available
through the London University Libraries (Table 1). Records were
screened by one study author (CV) and checked by a second author
(MH or LM), with disagreements resolved through discussion. Study
quality was not assessed because study quality criteria, such as the
CASP checklist,12 seemed too dependent on study reporting and did
not seem to adequately represent the contribution that studies could
make to the generation of a comprehensive overview of cancer fears
in the general population. This was due to references to cancer fear
in the included studies being infrequent. We therefore took an inclu-
sive approach in order to maximise our dataset and did not use study
quality as a selection criterion.2.4 | Data extraction
Data for each study were extracted to a tabulated pro‐forma with
columns for study characteristics and fear‐related findings (including
published theme titles, authors' interpretations, and participant
quotations) to incorporate the maximum contextual information in
our analyses. Study findings which were not about cancer fear
according to the definition given above were excluded. Three
researchers (CV, MH, and LM) extracted the data in parallel and
checked each other's data entry, with disagreements resolved through
discussion. During this process, the raw data were read several times
by these authors. Only published data were extracted, including
supplementary data. The aims of the review, the definition of cancer
fear, scope of the search, search strategy, inclusion and exclusionRationale/remarks
Mixed methods only if qualitative part fulfilled criteria
Most universally recommended cancer screenings
Primary qualitative data on cancer fear; not just mentioned in
introduction or discussion sections
For example, fear of test, test cost
For example, letters to the editor, reviews
For example, ‘key informant’ samples, such as community leaders
Fears may be different from average risk samples.
No longer considerate adequate methods of breast screeninga
r early detection of breast cancer. Cochrane Database Syst Rev 2003; (2):
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before the searches were conducted (available from the first author
upon request).2.5 | Data analysis and meta‐synthesis
We used the thematic synthesis method described by Thomas and
Harden.13 After familiarising themselves with the dataset, two authors
(CV and GB) annotated the extracted data extensively with initial
impressions and interpretations, and generated a number of descrip-
tive codes following semantic content. These were grouped into a hier-
archy of analytical themes and reconfigured many times in theoretical
discussion with each other and the other study authors to establish a
coherent structure with constant reference to quotations and authors'
interpretations to verify the developing interpretation. This hierarchy
was discussed with the whole analysis team (CV, GB, LM, and MH),
and this feedback led to some adjustments in two theme interpreta-
tions. For the updated literature search (June 2013–March 2015),
two authors (CV and GB) annotated the dataset and discussed any
new emerging themes. This additional dataset confirmed the robust-
ness of our earlier analysis and identified one new descriptive
subtheme, which was cross‐referenced with the earlier dataset (‘fears
that talking about cancer causes cancer’ in theme 3). No studies were
excluded based on quality. However, our analyses were primarily
based on the participant quotations found in the studies and less on
the authors' interpretations, which minimises the influence of poorer
quality studies' interpretations on our findings. Studies with fewer
supporting quotes therefore also contributed less to the synthesis.3 | RESULTS
The electronic database searches yielded a total of 5077 results (initial
search: 4068, updated: 1009; Figure 1). After screening titles and
abstracts, 195 full‐text publications were assessed for eligibility, and
102 studies from 26 countries were included (59.8% North America,
17.6% Europe, 8.8% Middle East, 5.9% Africa, 2.9% Central and South
America, 2.9% Oceania, 2.0% Asia). The majority (78%) were publishedFIGURE 1 Flow chart of study inclusionbetween 2005 and 2015. Data were collected in focus groups (53%),
interviews (33%), a combination of these (8%), or a combination of sur-
vey and qualitative methods (6%). Reported data analysis methods
included content analysis (30.3%), thematic analysis and grounded the-
ory (both 8.8%), and various other methods (13.7%). The analytic
methods were described but not specified in 27.5% of studies, and
not described at all in 10.8%. Most studies focused on breast screening
(37%), followed by cervical screening (26%), colorectal cancer screen-
ing (25%), or a combination (12%).
Characteristics of the included studies are presented in Online
Supplement 1. All 102 studies together included more than 3500 par-
ticipants. The majority (74%) only included women, reflecting that two
of the three screenings are for women only, but the remaining 27
(>1250 participants) included both genders. A third of all studies
(34%) had an ethnically diverse sample of participants, just under a
third studied a single ethnic minority group (30%), and the remainder
did not specify the sample's ethnicity.
Only two studies explicitly sought to understand the role of cancer
fear in cancer screening (Online Supplement 1). Most studies explored
factors underlying the decision to participate in cancer screening, some
explored cultural meanings and experiences of cancer and screening,
and a small number aimed to inform the development of an interven-
tion. In most studies, fear was only one of a number of factors found
to influence screening practices, and references to cancer fear in these
studies were therefore infrequent. Because of the large number of
included studies, this review presents representative rather than com-
plete citations. Full results with complete citations are presented in
Online Supplement 2.4 | META‐SYNTHESIS
In our interpretation, people's fears were rooted in the meaning of can-
cer itself as a stealthy, indestructible, and indiscriminate killer,14–16
which we have labelled ‘cancer as the enemy’ (first theme). This enemy
elicits four threat appraisals:
• How close am I to this enemy? (second theme)
VRINTEN ET AL. 1073• How do I keep the enemy at bay? (third theme)
• What if the enemy attacks? (fourth theme)
• And finally, what if the enemy wins? (fifth theme)
Figure 2 presents the five analytical themes and subthemes.
People's fears do not follow a linear path along the appraisal stages,
but fears from different stages can be experienced simultaneously.5 | CANCER AS THE ENEMY
In approximately a quarter of all included studies, cancer fear was
linked to views of cancer as ‘an enemy’. Participants talked about can-
cer as if it were not just a disease, but a sentient persona with mali-
cious personality traits, such as viciousness, unpredictability, and
indestructibility.16–19 People described cancer as lurking inside you,
spreading stealthily and inescapably.19,20 By the time it revealed itself,
it was believed to be too late to do anything,18 which created a sense
of betrayal: ‘The cancer is a traitor… You can be examined all the time…
and nothing comes up, and then when you find out you have cancer it's
too late’.19 Echoing its strong association with death (see theme 5),
cancer was seen as an indiscriminate killer,16,20,21 that would return
endlessly despite treatment.16,19,22
Participants in several studies described cancer as a parasitising
organism that comes from outside and infects22 the body like
viruses,16 bacteria,16 or worms17,19,23 and which could be transmittedFIGURE 2 Analytical and subthemesto others.16,17,22 Notions of cancerous growth were strongly related
to destructive qualities, such as burning, rotting, or being eaten
away.16,23,24 The aggressive personality of cancer was a source of
much anxiety and fear.16,19,20,246 | HOW CLOSE AM I TO THE ENEMY?
In more than half of included studies, participants assessed their own
relationship to cancer in terms of proximity. Greater proximity
increased fear, and a greater distance reduced fear and created a
feeling of safety. Proximity was informed by cancer encounters, the
presence of symptoms, and assessments of personal risk.6.1 | Cancer encounters
Past encounters with cancer created a series of expectations about
cancer.15,16,19,21,25,26 Mass media campaigns could allay cancer fear
and encourage early detection behaviours16 but could also lead to con-
fusion when messages of increased survival ran counter to direct expe-
riences of cancer in others (see theme 5),19,21 which mainly seem to
shape people's cancer fear. In about a quarter of included studies, par-
ticipants related their fear to witnessing cancer's consequences in
friends and family,16,19–21,24,26–29 which ranged from seeing others
suffer the effects of chemotherapy and surgery28,29 to knowing people
who had died from cancer.16,19,20,26–28 These encounters inspired fear
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diagnosed with bilateral breast cancer. It brought up a lot of fear for
myself because […] I don't know if I could handle that’.29 For most
people, this fear motivated screening attendance16,26–29: ‘I don't like
being without (a mammogram) for a long time. So many people have
died of cancer. I'm afraid’.27 For others, it promoted screening
avoidance, usually because of coexisting negative beliefs about
treatment or survivability,21,26 which evoked a ‘I don't want to know
it before my time’ mind set.216.2 | Symptoms
Symptoms were believed to indicate greater proximity to cancer and
therefore inspired fear. In about a quarter of included studies,
participants felt reassured by an absence of symptoms, which was
seen as an indication that there was no need to attend
screening.14–17,22,25,28–31 A dominant belief was that medical
services are only for the sick,14,22,25 and only the appearance of
symptoms would signal advancing cancer and prompt screening
attendance.14–17,25,29,30 Pain, in particular, was seen as an impor-
tant cue to action17,30: ‘If I'm not in pain, I think there's probably
no need [for screening]’.176.3 | Assessment of risk
Perceptions of causation, control, and risk of cancer were interrelated
factors indicating proximity to cancer. People distinguished causes and
risks that were perceived to be under individual control (discussed as
part of theme 3) from those that were not. Participants mentioned a
number of uncontrollable cancer risks, such as age and pollution,17,19
but only familial or genetic factors strongly influenced people's cancer
fear.15,16,20,24–26,28,32 Because familial risk could not be influenced
directly, participants tried to find other ways to allay their fears, such
as by adjusting their diet20 or participating in screening15,16,25,28: ‘[…]
I do have cancer in my family, and so that is what I'm afraid of. That's
one reason I have my Pap smear and my mammogram’.25 For some
participants, familial risk was such a strong risk indicator that a negative
family history led them to believe that there was no need to worry
about cancer or attend screening24: ‘So many women believe that it's
hereditary and that if they don't have it in the family, then what's the
purpose of doing it [getting a mammogram]?’.33
A dozen studies described people who were not afraid of cancer at
all, because they did not feel susceptible to it or had never experienced
it in anyone close to them. This was linked to a lack of motivation to
attend screening.17,26,34 In some of these studies,24,35 nonwhite eth-
nicity ameliorated cancer fear because some thought cancer was a
‘Western disease’ to which they were less susceptible, making screen-
ing unnecessary.24,35 ‘The [women's] attitudes rejecting of screening
were based on […] concerns about whether mammograms are as
effective for Chinese women as they are for Western women. This is
based on their belief that breast cancer is a “Western disease” and that
Caucasian women are prone to breast cancer as a result of having
larger breasts’.357 | HOW DO I KEEP THE ENEMY AT BAY?
Negative emotional states such as fear seldom remain unregulated.10
The third theme explores fears and worries associated with four
strategies to keep the enemy at bay.7.1 | Protecting yourself against cancer
In about a third of included studies, fear was regulated by controlling
certain risks. Relatively few studies mentioned lifestyle factors, such
as diet and exercise, as a means of controlling risks and allaying
fear.20,24 Instead, the focus was mainly on other factors that were
deemed risky, such as worrying about cancer, and cancer screening.
Some believed that cancer could be the result of worrying, think-
ing, or talking about cancer.14,26 They believed that worrying induced
stress, which could facilitate cancer development, and so they worried
about being worried about cancer, constituting a form of meta‐
worry14,24: ‘Just by worrying can we become sick. […] I always worry
and that I might get cancer’14 Others believed that thinking or talking
about cancer was risky,20–22,24,29,36 ‘fearing that just uttering the word
[cancer] would result in getting the disease’36 and thus avoided the
topic of cancer.
Of the 49 studies about breast cancer screening, more than a
quarter mentioned the screening itself as a risky activity that was
best avoided because of the radiation15,16,18,21,25,35 and compres-
sion involved15,28,35: ‘I heard that they have to press your breasts
until they can fit into the machine. […] What if […] it hurts my
breasts and I develop cancer later. Who knows?’.35 Compression
during mammography was also linked to fears of a tumour bursting
and spreading,37 and therefore best avoided. Breastfeeding, on the
other hand, was seen to protect against breast cancer, and thus
reduced cancer fear.16,247.2 | Check the enemy's progress through screening
Screening presents an opportunity to obtain reassurance by checking
up on cancer's progress, but nearly a third of included studies
described how facing the prospect of this knowledge can (usually tem-
porarily) induce cancer fear. Some reported an intense fear, almost cul-
minating in an expectation, that the test would reveal a cancer
diagnosis.14,29,30 ‘[I'm afraid of] what they might find. That is my big-
gest fear […]’.30 Furthermore, a positive test result was often seen as
a direct indicator of having cancer, leading to anxiety about the
moment the results were received.19,21,36–38
Having to wait for results prolonged anxiety until the ‘all clear’
was given.20,30,39 Other factors that enhanced anxiety about cancer
were recalls, only being contacted if further tests were needed
(which created prolonged anxiety about having missed the call39),
and unclear communication of results including benign find-
ings,18,19,24,30,37 which put some people off reattending screening,
sometimes permanently18: ‘The doctor [said] oh it's just calcium
deposits—which took 30 years off my life’.37 Thus, some people
use screening to reduce cancer fear, but the screening test itself is
also fear provoking.
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behalf
A third strategy to allay cancer fear is to trust in someone who will
guard against cancer on your behalf. In some studies, people delegated
this responsibility to their doctor, and lacking a doctor's recommenda-
tion for screening was sometimes reassuringly interpreted that there
was no need to worry.17,18,21 More commonly, however, participants
reduced their fear of cancer by looking to God.
Religion was invoked in about a quarter of included
studies.14–16,18–20,22–24,27,30,32,36,38,40 In some studies, this was only
to help cope with fear of cancer,20,22,27,40 but the majority of partici-
pants also used it to abdicate their own agency over the threat of
cancer14–16,18,19,23,25,30,32,36,38: ‘I don't worry about [breast cancer
screening] because only God can decide when it's my time to go.’30
These participants saw cancer as part of God's plan or test, and their
own role as one of acceptance and patience.18,30,38 This view was
associated with lower motivation to attend screening.7.4 | Ignoring the enemy
Participants in more than half of included studies chose to ignore the
existence of cancer altogether, because they were too fearful of being
diagnosed. Statements such as ‘ignorance is bliss’,38 and ‘what you
don't know you don't worry about’41 were often used to explain why
they did not participate in screening.16,18,22–24,36–39,41 They prioritised
feeling good or normal over the relative advantages of early detec-
tion19,22,31–34,36,37,41 and avoided screening tests because they consid-
ered them as taking an unnecessary risk of finding cancer23,34 as if
spontaneously making it appear: ‘I have this fear that if I check for it
and I find something then my life is gonna change. But […] if I don't
check, I don't find anything and nothing changes’.34
In about a sixth of included studies, participants ignored the threat
of cancer because it competed with more pressing worries, such as
other health problems31,34 or struggles to meet the demands of every-
day life.21,24,28,31,34 This was especially prominent in those from poorer
backgrounds and developing countries.8 | WHAT IF THE ENEMY ATTACKS?
Although all reviewed studies were conducted in healthy populations,
many participants expressed fears about being a cancer patient, which
could be subdivided into fears about the emotional and physical conse-
quences of a cancer diagnosis, and its social consequences.8.1 | Emotional and physical implications of being a
cancer patient
Fears about the emotional and physical consequences of a cancer
diagnosis were mentioned in more than half of included studies. In a
quarter of included studies, participants mentioned fears about how
to emotionally ‘handle’ a cancer diagnosis, expecting to feel
devastated, anxious, sad, and depressed14,16–18,23,24,29,32,36,38–40 and
having their world fall apart: ‘You can go in there [ie, screening]thinking nothing is wrong and come out with your whole life being
changed’.32
Fear of the physical implications included fears about the disease
course and its treatments. Some were afraid of cancer's spread and
feared that it would be too late to stop it by the time it was
detected,15,18,22,29,38 but fears associated with cancer treat-
ments15,16,19,20,23–25,30,31,36,38 such as pain, suffering, and bodily
changes (including hair loss and resection scars) were more
prevalent and were mentioned in more than 40 studies. Chemother-
apy20,36 and surgery15,16,20,22–25,27–30,38–42 were particularly fearful,
partly stemming from cancer encounters in others (see also theme 2).
Fear of surgery was also expressed as a fear of having body parts cut
off and deformed, particularly if this would be visible to
others16,20,23–25,27,29,41: ‘[…] I would prefer to die and be buried in
one piece than being cut and sold by kilo’.16
In the context of breast and cervical screening, some women
expressed fears of losing intimate body parts. The breasts (and to a
lesser extent the cervix) were widely considered to be symbols of
femininity and motherhood,16,23,24,28,39,40,42 and losing these body
parts was likened to being ‘less of a woman’28:For many of our informants, the breast was not simply an
organ, but a symbol of femininity. Therefore they saw
breast cancer as not only threatening their lives, but
also their womanhood, since most believed that breast
cancer would always lead to the removal of the breasts.
[…] Because breast cancer was seen as a ‘lady‐killer’,
informants were doubly fearful of the disease. Typical
comments were ‘If I lose my breasts, I will no longer feel
I'm a woman’ and ‘I think breast cancer is the most
scary disease for a woman because it takes away the
breasts’ [42, breast, Australia].For some, fear of surgery was enhanced by the belief that cutting
cancer causes it to spread22,30 and cannot provide a long‐term
cure16,18–22,38: ‘But you also hear the rumours where people have
been opened up and it seemed like when they were opened up, the
cancer spread. And I think that is my biggest fear’.22 Fears of treatment
led to screening avoidance,15,20–24,31,36,38,41 although there were some
exceptions.15,29,318.2 | Social implications of being a cancer patient
Fears about the social consequences of a cancer diagnosis were men-
tioned in about a third of included studies. Half of these mentioned
fears about others' reactions, such as being stigmatised or
blamed,14,16,22,25,26,35,36,40,42 since cancer was sometimes seen as a
punishment for sins or bad karma.14,42 Cervical and breast cancer were
associated with promiscuous behaviour, provoking fears of social
rejection and gossip42: ‘[Women] are worried about what will people
say, […] questions will be raised and I will have to feel ashamed’.26
Some therefore preferred to avoid screening to avoid being
diagnosed.26,35,36,40
About a sixth of included studies mentioned fears about the finan-
cial, physical, or psychological consequences of a cancer diagnosis on
the immediate family15,16,20,23,24,31,35,36,38: ‘[A diagnosis of cancer]
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den on your family when you're so sick’.38 In addition, many women
feared partner rejection and abandonment after cancer treat-
ment.16,24,28,30,36,40 They felt that cancer treatment, particularly for
breast cancer, would leave them incomplete, unattractive, and sexually
compromised, which they felt would render them worthless as a wife
or mother16,17,24,28,30,36: ‘[…] The first thing to come to mind is “Oh,
[my husband] is going to get another woman now… I'm no longer
attractive”30. These fears were linked to preferences for screening
avoidance,24,35,36,38 although there were again some exceptions.15,319 | AND FINALLY, WHAT IF THE ENEMY
WINS?
The last theme consists of fears about mortality. ‘Death’ was an inher-
ent meaning of cancer in more than a third of included studies, and this
was a source of intense fear14, 16, 20–25, 28, 30, 36, 38, 39, 42: ‘[…] as soon
as you hear cancer you think of the ultimate. There's nothing more
then, but for this person to die’.39 Some participants were unable to
reconcile messages from doctors and the media about improved
cancer survival with what they had experienced or feared to be the
case, which sometimes led to confusion19–21: ‘They say that you don't
die from cancer and everyone does’.19
Some said that it was better to die without knowing you had
cancer,16,23,24,28,36 suggesting that fear of dying is also fear of knowing
it would happen: ‘I'd rather not go [for screening], that way the doctor
can't tell me that I have cancer, because just by knowing, that I will die,
[…] I would die.[…] From knowing. From the fear’.24 This may be
related to the ‘ignorance is bliss’–type approach to cancer as described
in theme 3. The high prevalence of fears about mortality in general
suggests that the association of cancer with death is still very promi-
nent, cross‐cultural and, together with fears about what it is like to
be a cancer patient (theme 4), perhaps the most important component
of cancer fear.10 | DISCUSSION
This meta‐synthesis aimed to explore and categorise cancer fears in
the general population. It drew out the multidimensionality of cancer
fear, with a view of cancer as an enemy at its core—reprising the
‘war on cancer’ theme that dominates the media.43 Cancer fears
related to perceptions of proximity; the strategies to keep the enemy
at bay; the emotional, physical, and social implications of disease; and
dying. We identified factors that enhanced or diminished cancer fear,
such as cancer encounters or symptoms, and factors that could
become objects of fear in themselves, such as screening and treatment.
People's fear seemed to be rooted in their view of cancer as an
enemy, which raises important questions about where this view comes
from and the effects it has. The cancer experience became imbued
with militarism in the previous century, possibly to secure funding for
cancer research.44 Today, war and violence metaphors are still often
used by cancer charities in fundraising campaigns. The metaphor was
also adopted by the mass media43 and made its way into the discourse
of individual patient experience,45 a development that may have beenreinforced by the idea that ‘a fighting spirit’ could improve survival.46
Although no evidence has been found to support this claim, the
fighting metaphor stuck.
The war metaphor for cancer has recently become criticised, how-
ever. Patients object to the blame it may to attribute to them for ‘not
winning their battle’,45 and recent evidence suggests that it may have
detrimental effects on some cancer‐prevention behaviours.47 Cam-
paigns that portray cancer as an enemy, such as charity fundraising
campaigns, may discredit public health messages about prevention
and early detection of cancer. This could result in increased cancer
worry and scepticism about the preventability of cancer, which are
associated with lower adherence to recommendations regarding
smoking, exercise, and fruit and vegetable intake, making the metaphor
potentially harmful for public health.48,49 Indeed, in our meta‐synthe-
sis, we noted an absence of references to controllable lifestyle factors
in the risk assessments of those who were fearful, and very little use of
behavioural strategies to reduce cancer risk and allay cancer fear,
despite current estimates that about 40% of cancers in developed
countries are due to lifestyle choices.50 Although more research into
the causal link between enemy metaphors and diminished cancer pre-
vention behaviours is needed, we caution that campaigns that appeal
to the intuitive sense of cancer dread and endorse and exploit people's
fear of cancer may impede the adoption of cancer‐preventive health
behaviours. Getting rid of mixed messages in the public portrayal of
cancer may thus be a key factor for future policies.
Our meta‐synthesis highlighted some other implications for public
health: a lack of symptoms, a negative family history of cancer, and
lower cancer risk perceptions among some ethnic minority groups all
reduced fear of cancer to the point where screening was seen as
unnecessary, and these erroneous beliefs may be targets for behaviour
change. The finding that symptoms are used as a way to gauge the
need for screening in about a quarter of studies is mirrored by quanti-
tative studies that suggest that a quarter to a third of the population
feel there is no need to screen in the absence of symptoms.51,52 In
addition, only a minority of common cancers are associated with a
hereditary predisposition, so a negative family history may provide a
false sense of security.53 Moreover, research shows that some ethnic
minority groups actually have a higher cancer burden,54,55 which is
partly attributed to their lower uptake of screening.56,57
Implications for future research follow from our finding that ‘can-
cer fear’ is not a single entity but consists of various interrelated fears
that may interact with pre‐existing beliefs to affect behaviour. For
example, the belief that a screening test could cause cancer meant that
the screening test became a proxy of cancer fear. Cancer fears could
also interact with each other. For example, the fear of cancer treat-
ment could outweigh the fear of dying from cancer. This meta‐synthe-
sis has generated tentative findings on the behavioural effects of
different cancer fears as they were reported in our qualitative dataset,
but these links warrant further evaluation in quantitative studies.
Our study may be limited by the infrequent references to cancer
fear in the included studies, but the large number of included studies
may have (at least partially) compensated for this. Generalisability
may also be limited because data were only collected in the context
of breast, cervical, and CRC screening. Future studies will need to
examine the robustness of this taxonomy in the wider general
VRINTEN ET AL. 1077population (eg, in less routine screenings, such as PSA testing, or out-
side of the cancer screening context). Although it is true that some
fears, such as of partner abandonment, were only expressed by
women, this does not necessarily mean that they are not experienced
by men—only that we did not find them in the sample of studies
included in this review. This gender bias may just be an artefact of
the types of screening included in the review, but future studies should
address the validity of this taxonomy of cancer fears in men. In addi-
tion, some fears may be more prevalent for certain types of cancer.
For example, womanhood issues may be more prevalent for breast
cancer than for colorectal cancer, and fears of being blamed or
stigmatised may be more prevalent for lung cancer than for some other
types of cancer. The aim of this review, however, was to explore and
categorise the fears that cancer (in general) evokes in the general pop-
ulation, and not to explore differences in cancer fears between cancer
types. Future studies should explore the prevalence of the various
fears for different types of cancer. We relied on the published quotes
and authors' interpretations for our analyses, which could mean we
missed some fears that were not mentioned in the published manu-
scripts. The prevalence or population distribution of cancer fears could
not be deduced from these qualitative studies.
Despite these limitations, we feel confident that we have
presented a robust taxonomy of cancer fears in the context of cancer
screening, because of the large number of triangulated studies, the
diversity of the study samples, and the fact that the updated literature
search only identified a single new subtheme. In addition, many of the
fears described in this review have also been described in studies of
other types of cancer screening,58,59 help‐seeking for cancer symp-
toms60,61 genetic cancer risk,62 and cancer patients,63 lending further
support to the idea that the cancer fears identified in this review are
universal.11 | CONCLUSIONS
This systematic review and synthesis of qualitative evidence drew out
the multidimensionality of cancer fear. Cancer fears emanated from a
core view of cancer as an enemy, evoking fears about its proximity,
the (lack of) strategies available to keep it at a distance, the personal
and social implications of succumbing, and dying from cancer. The view
of cancer as an enemy seems widely reinforced in society but may
impede effective cancer control strategies and the adoption of preven-
tive health behaviours. Future policies should focus on removing mixed
messages in the public portrayal of cancer.
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